Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/3/2025

Management of Sustained Bradycardia

Immediate Assessment and Intervention

  • For a patient with sustained heart rate of 36 BPM, immediately assess for hemodynamic instability and symptoms of poor perfusion—if present, administer atropine 0.5-1 mg IV as first-line therapy, repeatable every 3-5 minutes up to 3 mg total, while preparing for transcutaneous or transvenous pacing if medical therapy fails 1, 2
  • Signs of poor perfusion requiring immediate treatment include altered mental status, ischemic chest pain, acute heart failure, hypotension, or other signs of shock 3, 2
  • Obtain 12-lead ECG immediately to identify the rhythm mechanism 3, 2
  • Establish IV access, continuous cardiac monitoring, and pulse oximetry 3
  • A heart rate of 36 BPM is well below the 50 BPM threshold where bradycardia typically becomes symptomatic and requires intervention 3

Pharmacologic Management

  • Atropine has a Class IIa recommendation for symptomatic bradycardia with hemodynamic compromise 1
  • Atropine 0.5-1 mg IV push, repeat every 3-5 minutes to maximum total dose of 3 mg 1, 2
  • Contraindications for atropine include heart transplant patients without autonomic reinnervation and may worsen infranodal AV block 1, 5
  • Dopamine 5-20 mcg/kg/min IV and epinephrine 2-10 mcg/min IV are second-line treatments if atropine is ineffective 1, 2
  • Isoproterenol 1-20 mcg/min IV is an alternative, but avoid in suspected coronary ischemia 1

Temporary Pacing

  • Transcutaneous pacing is a Class IIb recommendation for immediate bridge therapy in critically ill patients 8, 9, 1
  • Transvenous pacing is a Class IIa recommendation for persistent hemodynamic instability refractory to medical therapy 8, 7
  • Transvenous pacing has a higher complication rate, but is more reliable than transcutaneous pacing 8

Clinical Decision Algorithm

  • Follow a structured approach for managing bradycardia, including atropine administration, pacing, and treatment of underlying causes 1, 2, 4
  • Recognize critical pitfalls to avoid, such as using atropine in heart transplant patients and rushing to permanent pacing within 72 hours of acute MI 1, 5, 9

Specific Rhythm Considerations

  • The underlying mechanism of bradycardia matters, with high-grade AV block and sinus bradycardia/sinus arrest having different responses to atropine and pacing 5
  • Acute MI with bradycardia has a better prognosis with inferior MI than anterior MI with conduction disease 5

REFERENCES

1

Bradycardia Treatment Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Bradycardia Management Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025